HIM
CRMD icon

Hillsdale Investment Management’s CorMedix CRMD Stock Holding History

Hillsdale Investment Management’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-600
Closed -$6.98K – 675
2025
Q3 		$6.98K Buy
600
+100
+20% +$1.21K ﹤0.01% 605
2025
Q2 		$6.16K Buy
+500
New +$5.52K ﹤0.01% 579

Other funds holding CRMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return

Hillsdale Investment Management's CRMD Position: Q4 2025 in Review

Hillsdale Investment Management sold out of CorMedix (CRMD) in Q4 2025, closing a stake of 600 shares — an estimated $6.98K sold.

Hillsdale Investment Management first reported a position in CRMD in Q2 2025 and held it in 2 quarters. The position peaked at $6.98K in Q3 2025. 198 funds tracked by Wall St. Rank hold CRMD as of Q4 2025.

  • Hillsdale Investment Management reported no remaining CorMedix position as of Q4 2025 after selling out during the quarter.
  • Hillsdale Investment Management sold 600 CorMedix shares in Q4 2025, an estimated $6.98K.
  • Hillsdale Investment Management first reported a position in CorMedix in Q2 2025 and held it in 2 quarters.
  • Hillsdale Investment Management's CorMedix position peaked at $6.98K in Q3 2025.
  • 198 funds tracked by Wall St. Rank held CorMedix as of Q4 2025.

Based on Hillsdale Investment Management's 13F filing for Q4 2025, filed 10 Feb 2026.